Evidence map›Paper›PMID 17952637›Full record

ArticleJournal of molecular neuroscience : MN2007

Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.

Eliezer Giladi, Joanna M Hill, Efrat Dresner, Conor M Stack, Illana Gozes

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01056965 (A 12 Week Randomized, Double Blind, Placebo-Controlled Pilot Study of Davunetide), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01056965 phase1completednot on this mapstarted 2010, after this paper: background citation

A 12 Week Randomized, Double Blind, Placebo-Controlled Pilot Study of Davunetide (NAP, AL-108) in Predicted Tauopathies

TypeinterventionalSponsorUniversity of California, San FranciscoRan2010 to 2012Enrolled12ConditionsPredicted Tauopathies, Including, Progressive Supranuclear Palsy, Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17, Corticobasal Degeneration SyndromeArmsdavunetide (AL-108, NAP), Placebo nasal spray
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Neuroprotective Peptides in Retinal Disease.Journal of clinical medicine · 2019
    Review
  6. Article
  7. Review
  8. ADNP Regulates Cognition: A Multitasking Protein.Frontiers in neuroscience · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2008
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Eliezer GiladiDepartment of Human Molecular Genetics and Biochemistry, Tel-Aviv University, Tel-Aviv, 69978, Israel.
Joanna M Hill
Efrat Dresner
Conor M Stack
Illana Gozes
Tel Aviv University · ILNational Institutes of Health · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Vasoactive intestinal peptide (VIP) is an important mediator of development during the neural tube closure period of embryogenesis and may regulate, in part, the expression of activity-dependent neuroprotective protein (ADNP), which is essential for neural tube closure and embryogenesis. To evaluate the impact of VIP expression in vivo on ADNP and the related protein ADNP2 the current study examined gene expression in adult wild-type (VIP +/+) and VIP null (VIP -/-) offspring of VIP deficient mothers (VIP+/-) comparing them to wild-type offspring of wild-type mothers. Quantitative real time polymerase chain reaction (PCR), using an ABI Prisma cycler revealed regionally specific reductions of ADNP mRNA in the brains of VIP null mice compared with the brains of wild-type offspring of a wild-type mother. ADNP was significantly reduced in the cortex and hypothalamus of VIP null mice, but not in the hippocampus or thalamus. ADNP2 exhibited a similar pattern but reached a statistically significant reduction only in the hypothalamus. The mRNA for ADNP and ADNP2 also tended to be reduced in the cortex and hippocampus of the wild-type littermates of the VIP null mice, indicating that the VIP genotype of the mother may have had an impact on the ADNP expression of her offspring, regardless of their own VIP genotype. These results showed that VIP regulated brain ADNP expression in a regionally specific manner and indicated that both maternal and offspring VIP genotype may influence ADNP expression in the brain.

Indexed as

AnimalsBrainFemaleHomeodomain ProteinsMiceMice, KnockoutNerve Tissue ProteinsNeuroprotective AgentsNeurulationPregnancyProtein IsoformsVasoactive Intestinal PeptideAdnp protein, mouseHomeodomain ProteinsNerve Tissue ProteinsNeuroprotective AgentsProtein IsoformsVasoactive Intestinal Peptide

Identifiers

PMID17952637
OpenAlexW2055733646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.